Cargando…

Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination

BACKGROUND: Antibodies with specificity for myelin oligodendrocyte glycoprotein (MOG) are implicated in multiple sclerosis and related diseases. The pathogenic importance of anti-MOG antibody in primary demyelinating pathology remains poorly characterized. OBJECTIVE: The objective of this study is t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berg, Carsten Tue, Khorooshi, Reza, Asgari, Nasrin, Owens, Trevor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483301/ https://www.ncbi.nlm.nih.gov/pubmed/28646890 http://dx.doi.org/10.1186/s12974-017-0899-1

Ejemplares similares

Cerebrospinal fluid aquaporin-4-immunoglobulin G disrupts blood brain barrier
por: Asgari, Nasrin, et al.
Publicado: (2015)

Hypersensitivity Responses in the Central Nervous System
por: Khorooshi, Reza, et al.
Publicado: (2015)

Selective localization of IgG from cerebrospinal fluid to brain parenchyma
por: Mørch, Marlene Thorsen, et al.
Publicado: (2018)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
por: Kim, Sung-Min, et al.
Publicado: (2015)

MOG antibodies in combined central and peripheral demyelination syndromes
por: Vazquez Do Campo, Rocio, et al.
Publicado: (2018)

Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Akaishi, Tetsuya, et al.
Publicado: (2016)

Defining distinct features of anti-MOG antibody associated central nervous system demyelination
por: Weber, Martin S., et al.
Publicado: (2018)

Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome
por: Wendel, Eva Maria, et al.
Publicado: (2022)

Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases
por: Serguera, Che, et al.
Publicado: (2019)

Tumefactive Demyelination—A Rare Presentation of Anti-MOG Syndrome
por: Sivadasan, Sesh, et al.
Publicado: (2022)

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
por: Ren, Bing-Yan, et al.
Publicado: (2021)

A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies
por: Hochmeister, Sonja, et al.
Publicado: (2020)

Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton
por: Dale, Russell C., et al.
Publicado: (2014)

Brain histopathological study and prognosis in MOG antibody‐associated demyelinating pseudotumor
por: Shu, Yaqing, et al.
Publicado: (2019)

COVID-19 vaccine associated demyelination & its association with MOG antibody
por: Netravathi, M., et al.
Publicado: (2022)

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
por: Ramanathan, Sudarshini, et al.
Publicado: (2018)

Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype
por: Pröbstel, Anne-Katrin, et al.
Publicado: (2015)

Innate Signaling in the CNS Prevents Demyelination in a Focal EAE Model
por: Dubik, Magdalena, et al.
Publicado: (2021)

Treatment Approaches for MOG-Ab-Associated Demyelination in Children
por: Hacohen, Yael, et al.
Publicado: (2019)

Epitope specificity of demyelinating MOG-specific autoantibody responses
por: Brehm, U., et al.
Publicado: (1998)

Coexistent anti-GFAP and anti-MOG antibodies presenting with isolated meningitis and papillitis: more support for overlapping pathophysiology
por: Martin, Andrew J, et al.
Publicado: (2022)

Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis
por: Khorooshi, Reza, et al.
Publicado: (2015)

Targeting Signaling Pathway Downstream of RIG-I/MAVS in the CNS Stimulates Production of Endogenous Type I IFN and Suppresses EAE
por: Kronborg Hansen, Anne K., et al.
Publicado: (2022)

The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults
por: de Mol, CL, et al.
Publicado: (2019)

Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases
por: Schanda, Kathrin, et al.
Publicado: (2021)

Refractory MOG-Associated Demyelinating Disease in a Pediatric Patient
por: Kroenke, Eve, et al.
Publicado: (2022)

COVID-19, HHV6 and MOG antibody: A perfect storm
por: Jumah, Muruj, et al.
Publicado: (2021)

Combined Central and Peripheral Demyelination in a Patient of Multifocal Motor Neuropathy and Positive Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibodies
por: Elterefi, Alanood E, et al.
Publicado: (2022)

Measles–rubella vaccine–associated MOG-antibody positive acute demyelinating encephalomyelitis with optic neuritis in a child
por: Otiv, Madhumati, et al.
Publicado: (2022)

Identification of circulating MOG-specific B cells in patients with MOG antibodies
por: Winklmeier, Stephan, et al.
Publicado: (2019)

An Experimental Model of Neuromyelitis Optica Spectrum Disorder–Optic Neuritis: Insights Into Disease Mechanisms
por: Soerensen, Sofie Forsberg, et al.
Publicado: (2021)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
por: Jarius, S., et al.
Publicado: (2018)

MOG antibody-associated diseases
por: Reindl, Markus, et al.
Publicado: (2015)

B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination
por: Kothur, Kavitha, et al.
Publicado: (2016)

Chemokine receptor expression by inflammatory T cells in EAE
por: Mony, Jyothi Thyagabhavan, et al.
Publicado: (2014)

Neurological update: MOG antibody disease
por: Wynford-Thomas, Ray, et al.
Publicado: (2018)

Leptomeningeal and Intraparenchymal Blood Barrier Disruption in a MOG-IgG-Positive Patient
por: Mohseni, Seyed Hamidreza, et al.
Publicado: (2018)

Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis
por: Chalmoukou, Konstantina, et al.
Publicado: (2015)

Reversible paraspinal muscle hyperintensity in anti-MOG antibody–associated transverse myelitis
por: Pandit, Lekha, et al.
Publicado: (2017)

Positive anti-MOG antibodies in a patient with Sjögren’s syndrome and transverse myelitis
por: Jobling, Kerry, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a8sub443k4tr0k0h85kmtddjiq